• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人血管加压素和催产素受体在大肠杆菌中的表达

Expression of human vasopressin and oxytocin receptors in Escherichia coli.

作者信息

Mouillac Bernard, Sen Tuhinadri, Durroux Thierry, Gaibelet Gérald, Barberis Claude

机构信息

INSERM U469, 141 rue de la Cardonille, 34094 Montpellier, France.

出版信息

Prog Brain Res. 2002;139:163-77. doi: 10.1016/s0079-6123(02)39015-0.

DOI:10.1016/s0079-6123(02)39015-0
PMID:12436934
Abstract

In order to produce large amounts of human vasopressin and oxytocin receptors compatible with direct structural biology approaches such as X-ray crystallography, NMR or mass spectrometry, we have expressed these neurohypophysial hormone receptors in Escherichia coli. To facilitate the level of expression, the coding sequence for the V1a vasopressin receptor and the oxytocin receptor were first optimized for bacterial expression. The resulting 'bacterial receptor cDNAs' were then subcloned into pET/T7-driven prokaryotic expression vectors. Different constructs have been prepared: each cDNA was incorporated alone or in fusion with a T7 tag sequence or a glutathione-S-transferase tag sequence at the N-terminus end. Moreover, a 6 x His tag sequence has been added at the C-terminus end for one-step purification of the receptors. Screening of BL21(DE3) and BL21(DE3)pLysS bacterial strains transformed with the different constructions was achieved by Coomassie blue-stained SDS-polyacrylamide gels and by 6 x His antibody Western blotting. Several clones were selected for purification of the receptors. Expression levels of the receptors are now encouraging and will be optimized for further structural and functional studies. Moreover, at the same time, the construction of the bacterial-optimized sequence of the V2 vasopressin receptor and its expression will be performed.

摘要

为了大量生产与X射线晶体学、核磁共振或质谱等直接结构生物学方法兼容的人血管加压素和催产素受体,我们已在大肠杆菌中表达这些神经垂体激素受体。为提高表达水平,首先对V1a血管加压素受体和催产素受体的编码序列进行了细菌表达优化。然后将得到的“细菌受体cDNA”亚克隆到pET/T7驱动的原核表达载体中。已制备了不同的构建体:每个cDNA单独整合,或在N末端与T7标签序列或谷胱甘肽-S-转移酶标签序列融合。此外,在C末端添加了一个6×组氨酸标签序列,用于受体的一步纯化。通过考马斯亮蓝染色的SDS-聚丙烯酰胺凝胶和6×组氨酸抗体免疫印迹法对用不同构建体转化的BL21(DE3)和BL21(DE3)pLysS菌株进行筛选。选择了几个克隆用于受体的纯化。受体的表达水平目前令人鼓舞,将针对进一步的结构和功能研究进行优化。此外,与此同时,将进行V2血管加压素受体的细菌优化序列构建及其表达。

相似文献

1
Expression of human vasopressin and oxytocin receptors in Escherichia coli.人血管加压素和催产素受体在大肠杆菌中的表达
Prog Brain Res. 2002;139:163-77. doi: 10.1016/s0079-6123(02)39015-0.
2
Molecular and cellular biology of vasopressin and oxytocin receptors and action in the kidney.血管加压素和催产素受体的分子与细胞生物学及其在肾脏中的作用
Curr Opin Nephrol Hypertens. 1994 Jan;3(1):46-53. doi: 10.1097/00041552-199401000-00006.
3
Identification of a single residue responsible for agonist selectivity in the oxytocin-vasopressin receptors.鉴定催产素 - 加压素受体中负责激动剂选择性的单个残基。
Ann N Y Acad Sci. 1997 May 30;812:218-21. doi: 10.1111/j.1749-6632.1997.tb48181.x.
4
Structural requirements for V2 vasopressin receptor proteolytic cleavage.
Eur J Biochem. 1999 Dec;266(2):538-48. doi: 10.1046/j.1432-1327.1999.00892.x.
5
Vasopressin and oxytocin: molecular biology and evolution of the peptide hormones and their receptors.
Vitam Horm. 1995;51:235-66. doi: 10.1016/s0083-6729(08)61040-7.
6
Vasopressin and oxytocin receptors.血管加压素和催产素受体。
Baillieres Clin Endocrinol Metab. 1996 Jan;10(1):75-96. doi: 10.1016/s0950-351x(96)80314-4.
7
Structure/function studies on receptors for vasopressin and oxytocin.血管加压素和催产素受体的结构/功能研究
Adv Exp Med Biol. 1998;449:363-5. doi: 10.1007/978-1-4615-4871-3_46.
8
Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling.鉴定参与配体结合和G蛋白偶联的神经垂体激素受体结构域。
Adv Exp Med Biol. 1998;449:371-85. doi: 10.1007/978-1-4615-4871-3_48.
9
Molecular aspects of vasopressin receptor function.血管加压素受体功能的分子层面
Adv Exp Med Biol. 1998;449:347-58. doi: 10.1007/978-1-4615-4871-3_44.
10
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.血管加压素/催产素受体家族中激动剂选择性的分子基础。
Adv Exp Med Biol. 1995;395:321-8.

引用本文的文献

1
Directed evolution for high functional production and stability of a challenging G protein-coupled receptor.针对具有挑战性的G蛋白偶联受体进行高效功能表达和稳定性的定向进化。
Sci Rep. 2021 Apr 21;11(1):8630. doi: 10.1038/s41598-021-87793-9.
2
Leukotriene BLT2 receptor monomers activate the G(i2) GTP-binding protein more efficiently than dimers.白三烯 BLT2 受体单体比二聚体更有效地激活 G(i2) GTP 结合蛋白。
J Biol Chem. 2010 Feb 26;285(9):6337-47. doi: 10.1074/jbc.M109.083477. Epub 2009 Dec 21.